Table 1.
Classification and clinical rheumatological data of 26 JIA patients
| Normal TMJ* group n = 11 |
Abnormal TMJ group n = 15 |
p-values | |||
|---|---|---|---|---|---|
| ILAR diagnosis** | |||||
| Oligoarthritis | 3 | (27%) | 4 | (27%) | |
| Extended oligoarthritis | 4 | (27%) | |||
| Polyarthritis, rheumatoid factor positive | 2 | (18%) | 3 | (20%) | |
| Polyarthritis, rheumatoid factor negative | 1 | (7%) | |||
| Systemic arthritis | 3 | (27%) | 2 | (13%) | |
| Enthesitis related arthritis | 2 | (18%) | 1 | (7%) | |
| Psoriatic arthritis | 1 | (9%) | |||
| Disease onset age (years) | 6.4 | ± 2.9 | 3.8 | ± 1.9 | 0.012 |
| Disease duration at final follow-up (years) | 27.4 | ± 2.3 | 30.1 | ± 2.9 | 0.017 |
| Mean age at final follow-up (years) | 33.7 | ± 2.6 | 33.9 | ± 3.0 | 0.72 |
| Disease variables at final follow-up: | |||||
| Number of active joints (range 0-69) | 1.0 | ± 1.4 | 10.4 | ± 15.0 | 0.033 |
| Number of joints with limited range of motion (range 0-69) | 3.2 | ± 4.7 | 24.9 | ± 23.6 | 0.009 |
| Physician's global assessment (0-100 mm VAS) | 9.4 | ± 19.1 | 24.9 | ± 30.0 | 0.064 |
| Patient's global assessment (0-100 mm VAS) | 4.8 | ± 9.6 | 31.6 | ± 17.4 | 0.001 |
| Physical function (HAQ disability index, range 0-3) | 0.5 | ± 0.7 | 0.6 | ± 0.6 | 0.23 |
Values are the number of patients (%), or the mean ± SD
* TMJ = temporomandibular joint
** Patients were classified at the final follow-up with old and new patient files at hand